Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13608* | 2021 |
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis AL Gartel, AL Tyner Molecular cancer therapeutics 1 (8), 639-649, 2002 | 1264 | 2002 |
Lost in transcription: p21 repression, mechanisms, and consequences AL Gartel, SK Radhakrishnan Cancer research 65 (10), 3980-3985, 2005 | 1064 | 2005 |
Transcriptional regulation of the p21 (WAF1/CIP1) gene AL Gartel, AL Tyner Experimental cell research 246 (2), 280-289, 1999 | 888 | 1999 |
p21—negative regulator of the cell cycle AL Gartel, MS Serfas, AL Tyner Proceedings of the Society for Experimental Biology and Medicine 213 (2 …, 1996 | 567 | 1996 |
Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3 AL Gartel, X Ye, E Goufman, P Shianov, N Hay, F Najmabadi, AL Tyner Proceedings of the National Academy of Sciences 98 (8), 4510-4515, 2001 | 554 | 2001 |
Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage ES Kandel, J Skeen, N Majewski, A Di Cristofano, PP Pandolfi, ... Molecular and cellular biology 22 (22), 7831-7841, 2002 | 394 | 2002 |
Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes AL Gartel, K Shchors Experimental cell research 283 (1), 17-21, 2003 | 342 | 2003 |
ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors M Halasi, M Wang, TS Chavan, V Gaponenko, N Hay, AL Gartel Biochemical Journal 454 (2), 201-208, 2013 | 331 | 2013 |
Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1 SK Radhakrishnan, UG Bhat, DE Hughes, IC Wang, RH Costa, AL Gartel Cancer research 66 (19), 9731-9735, 2006 | 267 | 2006 |
Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells UG Bhat, M Halasi, AL Gartel PloS one 4 (5), e5592, 2009 | 255 | 2009 |
FOX (M1) news—it is cancer M Halasi, AL Gartel Molecular cancer therapeutics 12 (3), 245-254, 2013 | 241 | 2013 |
FoxM1 is a general target for proteasome inhibitors UG Bhat, M Halasi, AL Gartel PloS one 4 (8), e6593, 2009 | 231 | 2009 |
FOXM1 in cancer: interactions and vulnerabilities AL Gartel Cancer research 77 (12), 3135-3139, 2017 | 196 | 2017 |
RNA interference in cancer AL Gartel, ES Kandel Biomolecular engineering 23 (1), 17-34, 2006 | 196 | 2006 |
Targeting FOXM1 in cancer M Halasi, AL Gartel Biochemical pharmacology 85 (5), 644-652, 2013 | 188 | 2013 |
miRNAs: Little known mediators of oncogenesis AL Gartel, ES Kandel Seminars in cancer biology 18 (2), 103-110, 2008 | 176 | 2008 |
p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line AL Gartel, MS Serfas, M Gartel, E Goufman, GS Wu, WS El-Deiry, ... Experimental cell research 227 (2), 171-181, 1996 | 152 | 1996 |
Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc A Datta, A Nag, W Pan, N Hay, AL Gartel, O Colamonici, Y Mori, ... Journal of Biological Chemistry 279 (35), 36698-36707, 2004 | 148 | 2004 |
Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle SK Radhakrishnan, CS Feliciano, F Najmabadi, A Haegebarth, ... Oncogene 23 (23), 4173-4176, 2004 | 147 | 2004 |